Female pattern andrpgenetic alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Control group
Topical 2% Progesterone solution, twice a day for 24 weeks. Intervention 2: Intervention group
Topical 5% Spironolactone solution, twice a day for 24 weeks.
Treatment - Drugs
Control group
Topical 2% Progesterone solution, twice a day for 24 weeks
Intervention group
Topical 5% Spironolactone solution, twice a day for 24 weeks
Sponsors
Vice Chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: female; grade 1 or 2 androgenetic alopecia; no underlying hormonal disorders Exclusion criteria: patient's decision to exit the study; underlying hormonal disorder; anemia; use of topical medications in the past week; taking oral medications in the past four weeks; have allergy to spironolactone or progesterone; pregnancy or planning to pregnancy or breastfeeding
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density per squared cm, Hair diameter. Timepoint: At baseline, 8th, 16th ,24th weeks. Method of measurement: Trichoscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: At baseline, 8th, 16th and 24th weeks. Method of measurement: Qualitative. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHerizchi ghadim Hamideh
Tabriz University of Medical Siences
Outcome results
None listed